Piermont Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1.34M	Buy	39,950 +800	+2%	+$28.9K	0.64%	84
2018 Q3	$1.65M	Sell	39,150 -5,974	-13%	-$236K	0.66%	87
2018 Q2	$1.44M	Buy	45,124 +1,800	+4%	+$74.1K	0.44%	104
2018 Q1	$2.15M	Buy	43,324 +5,040	+13%	+$285K	0.72%	52
2017 Q4	$2.06M	Sell	38,284 -1,540	-4%	-$85.2K	0.68%	67
2017 Q3	$2.31M	Hold	39,824	–	–	0.76%	52
2017 Q2	$1.97M	Sell	39,824 -10,176	-20%	-$469K	0.56%	65
2017 Q1	$2.17M	Sell	50,000 -3,535	-7%	-$169K	0.52%	81
2016 Q4	$2.62M	Sell	53,535 -3,604	-6%	-$167K	0.6%	65
2016 Q3	$2.73M	Sell	57,139 -23,349	-29%	-$1.15M	0.65%	58
2016 Q2	$4.32M	Buy	80,488 +66,788	+488%	+$3.15M	1.12%	2
2016 Q1	$613K	Sell	13,700 -300	-2%	-$12.2K	0.2%	126
2015 Q4	$534K	Sell	14,000 -1,240	-8%	-$47.4K	0.17%	134
2015 Q3	$485K	Hold	15,240	–	–	0.16%	134
2015 Q2	$503K	Sell	15,240 -500	-3%	-$17.8K	0.15%	167
2015 Q1	$648K	Buy	15,740 +5,360	+52%	+$217K	0.2%	126
2014 Q4	$423K	Sell	10,380 -140	-1%	-$5.47K	0.15%	114
2014 Q3	$386K	Buy	10,520 +4,690	+80%	+$203K	0.15%	114
2014 Q2	$270K	Hold	5,830	–	–	0.11%	109
2014 Q1	$240K	Hold	5,830	–	–	0.12%	111
2013 Q4	$222K	Buy	+5,830	New	+$180K	0.11%	112